Serum-associated inhibition of leukotaxis in humans with cancer
- 1 February 1978
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 9 (2) , 166-176
- https://doi.org/10.1016/0090-1229(78)90068-5
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- How Lymphocytes Kill Tumor CellsNew England Journal of Medicine, 1976
- Leukotactic Dysfunction in SarcoidosisAnnals of Internal Medicine, 1976
- Antileukotactic properties of tumor cells.Journal of Clinical Investigation, 1975
- Two Distinct Chemotactic Factor Inactivators in Human SerumThe Journal of Immunology, 1975
- Defective Regulation of Inflammatory Mediators in Hodgkin's DiseaseNew England Journal of Medicine, 1974
- FORMATION OF C3a AND C5a ANAPHYLATOXINS IN WHOLE HUMAN SERUM AFTER INHIBITION OF THE ANAPHYLATOXIN INACTIVATORThe Journal of Experimental Medicine, 1973
- Immunodeficiency Disease and MalignancyAnnals of Internal Medicine, 1972
- THE REQUIREMENT OF SERINE ESTERASE FUNCTION IN COMPLEMENT-DEPENDENT ERYTHROPHAGOCYTOSISThe Journal of Experimental Medicine, 1969
- DELAYED HYPERSENSITIVITY RESPONSE TO DNFB IN SICK AND HEALTHY PERSONS*Annals of the New York Academy of Sciences, 1964
- A Method for Determining the Sedimentation Behavior of Enzymes: Application to Protein MixturesJournal of Biological Chemistry, 1961